ER homeostasis is vital for cellular function and survival. Alterations in the folding capacity of the ER due, for example, to changes in calcium storage, may cause accumulation of unfolded or misfolded proteins in the lumen and ER stress. To safeguard homeostasis, the mammalian ER contains transmembrane proteins that sense stress in the lumen and trigger a complex series of signals collectively termed unfolded protein response (UPR; [@bib19]; [@bib56]; [@bib55]). The UPR reduces the load of abnormal protein in the ER and improves the capacity of the ER to fold proteins and degrade terminally misfolded proteins. An adaptive response is achieved through two main mechanisms: translational attenuation, via phosphorylation of the translation initiation factor eIF2α, and activation of transcription factors like ATF6 and XBP-1, which increase the expression of chaperones, such as BiP, and other proteins, such as Derlins, that facilitate ER-associated degradation (ERAD). However, if the accumulation of misfolded proteins persists, the UPR may become maladaptive and activate apoptosis through transcription factors such as CHOP ([@bib77]; [@bib63]). What determines the switch from adaptive to maladaptive response is a fundamental unanswered question ([@bib56]); [@bib30].

Myelin synthesis by oligodendrocytes and Schwann cells requires massive production of lipids and proteins. Not surprisingly, ER stress has been implicated in myelin disorders in both the central nervous system (CNS) and the peripheral nervous system (PNS; [@bib10]; [@bib29]; [@bib36]). Myelin protein zero (*Mpz*; P0) is the major protein synthesized during terminal differentiation of myelinating Schwann cells. It accounts for 20--50% of the total protein in myelin ([@bib21]; [@bib50]) and is essential for its compaction and maintenance ([@bib16]). In humans, diverse mutations in P0, most inherited as dominant traits, cause a range of hereditary neuropathies, suggesting different types of toxic gain of function ([@bib73]). However, the pathogenetic mechanisms remain poorly understood ([@bib73]; [@bib5]; [@bib59]).

Deletion of serine 63 (P0S63del) causes a Charcot-Marie-Tooth type 1B (CMT1B) disease ([@bib25]), a demyelinating neuropathy characterized by myelin destruction and failed attempts to remyelinate (onion bulbs; [@bib35]).We have shown in transgenic mice that P0S63del is not detected in the myelin sheath, but is retained in the ER, where its accumulation triggers a canonical UPR, indicating a toxic gain of function ([@bib74]; [@bib51]). Notably, in S63del mice the genetic ablation of *Chop* completely rescues the motor deficit and ameliorates the demyelinating phenotype indicating that the UPR is pathogenetic ([@bib51]).

To understand the contribution of the UPR and CHOP to demyelination in S63del nerves, we compared the pool of mRNAs in nerves of WT, S63del, and *Chop*-null mice at various points in development and found that the UPR is a specific feature of S63del nerves, detectable soon after birth and sustained throughout life. We identify the phosphatase Gadd34, a reactivator of protein translation in the context of the UPR ([@bib44]), as a target gene of CHOP also in S63del nerve. Genetic and pharmacological assessment of Gadd34 in S63del peripheral neuropathy suggest that regulation of eIF2α and protein translation are candidate therapeutic targets for peripheral neuropathy associated with altered proteostasis and possibly for other misfolded protein diseases.

RESULTS
=======

Although UPR and *Chop* are pathogenetic in S63del neuropathy, the timing and amount of apoptosis suggest that the death of Schwann cells is a consequence, not cause, of demyelinating neuropathy. Therefore, we speculated that the UPR contributes to demyelination by other maladaptive effects ([@bib51]). To further elucidate the molecular mechanisms involved in the neuropathy and in the rescue after the ablation of *Chop*, we characterized the transcriptome of sciatic nerves from WT, *Chop*-null, S63del, and S63del/*Chop*-null mice at three different time-points: (1) postnatal day 5 (P5), when myelination has begun and only the primary effects of the presence of P0S63del should be detected; (2) P28, around the peak of myelination and P0S63del expression, when all targets of CHOP should be activated; and (3) 4 mo, when the motor and morphological rescue caused by the ablation of *Chop* were clearly detectable ([@bib51]).

Expression of P0S63del causes broad transcriptional alterations in nerve
------------------------------------------------------------------------

We first characterized the transcriptome of S63del nerves, to understand the pathological events occurring in CMT1B nerves ([Fig. 1 A](#fig1){ref-type="fig"}). We observed that P0S63del extensively perturbs gene expression following on the expression of the *Mpz*-based S63del transgene ([Fig. 1 B](#fig1){ref-type="fig"}); in fact, as early as P5, when the transgene is already robustly expressed ([@bib11]; [@bib74]), 771 genes were found to vary (increased or decreased) by \>1.5-fold compared with WT; this number rose to 1,205 genes at P28, when myelination peaks, and decreased to 324 genes at 4 mo, when myelin genes, and thus the *Mpz*S63del transgene, are expressed at lower levels ([@bib74]).

![**Transcriptional profiling reveals a robust stress response in S63del nerves.** (A) Hierarchical clustering of P5 sciatic nerves from WT, *Chop*-null, and P0S63del mice. (B) The number of genes that vary in S63del at different stages of myelination. (C) L2L analysis of the S63del group of genes up-regulated in P5 nerves shows an enrichment for the GO categories related to stress response. (D) Quantitative RT-PCR analysis on P28 sciatic nerves to validate a selection of UPR/ERAD-related genes, and early Schwann cell transcription factors. Error bars, SEM; *n* = 4--6 RT from independent pools of P28 nerves. \*, P \< 0.05; \*\*, P \< 0.01, Student's *t* test.](JEM_20122005R_Fig1){#fig1}

P0S63del activates a robust stress response in transgenic mice
--------------------------------------------------------------

Manual curation of the sets of genes up-regulated in S63del nerves (Table S1) suggested that the expression of P0S63del immediately affects cellular homeostasis. In fact, in S63del nerves at P5, the genes with the highest level of induction were related to the heat shock response, such as *Hsp1*, *1a*, and *1b*, along with known members of the UPR (*Chop*, *Atf3*, *Asns*-asparagine synthetase; [@bib4]) and of the ER-associated degradation (ERAD) complex (*Derl3*-Derlin-3; [@bib46]). Other genes were up-regulated that only recently have been associated with the UPR, such as *Trb3* ([@bib48]) stromal cell--derived factor 2-like 1 (*Sdf2l1*; [@bib14]), and cysteine-rich with EGF-like domains 2 (*Creld2*; [@bib47]). Finally, we observed markers of inflammation, such as chemokine (C-X-C motif) ligand 10 and 14 (*Cxcl10* and *Cxcl14*), and the tumor necrosis factor receptor superfamily, member 12a (*Tnfrsf12a*).

At P28, when *Mpz*S63del is expressed at the highest level, the sets of altered genes were more heterogeneous. Many genes related to UPR/ERAD like *Chop*, *Sdf2l1*, and *Derl3* were still up-regulated, although the heat shock response was attenuated. More genes related to inflammation, such as serum amyloid A1 (*Saa1*), *Tnfrsf12a*, and *Cxcl14*, and to protein transport, such as members of the sorting nexin family (*Snx6* and *Snx16*), were up-regulated. Interestingly, there was also induction of genes encoding transcription factors that are usually characteristic of pre and pro-myelinating Schwann cells, such as *Pou3f1*/*Oct6*, *Id2*, *c-Jun*, *Sox2*, and *Sox4* ([Fig. 1](#fig1){ref-type="fig"} and [Table S1](http://www.jem.org/cgi/content/full/jem.20122005/DC1){#supp1}). Importantly, c-Jun, Sox2, and Id2 are thought to act as negative regulators of myelination ([@bib26]; [@bib33]; [@bib49]; [@bib2]).

At 4 mo, the expression of *Mpz*S63del is lower, similar to endogenous *Mpz*, ([@bib11]), even though demyelinating neuropathy becomes more evident in S63del nerves ([@bib74]), similar to patients with *MPZ*S63del, in whom neuropathy appears gradually over the first two decades of life ([@bib35]). Accordingly, transcriptomic analysis showed that the majority of the up-regulated genes were related to inflammation, a typical consequence of demyelinating neuropathy. Less stress response was detectable (*Chop* up-regulation was ∼1.6-fold), which is consistent with lower expression of P0S63del. Finally, the early Schwann cell transcription factor genes remained significantly up-regulated.

Although manual curation improves the choice of where to assign genes among Gene Ontology (GO) categories, the different numbers of genes contained among GO categories introduces bias. Therefore, we performed an unbiased analysis using the software L2L ([@bib42]). L2L automates annotation of a list of genes with GO categories, corrects for overrepresentation of the category in the list, and measures statistical significance. This analysis indicated that the GO category named "response to unfolded protein" was highly enriched (12-fold) in P5 nerves from S63del versus WT, confirming that P0S63del quickly activates a robust stress response ([Fig. 1 C](#fig1){ref-type="fig"}). Most GO categories enriched at P5 were functionally related, such as stress response, protein folding, or protein catabolism.

In P28 sciatic nerves, L2L analysis again showed enrichment for the GO categories ER--nuclear signaling pathways (11-fold) and the response to unfolded protein (5.7 fold; [Fig. S1](http://www.jem.org/cgi/content/full/jem.20122005/DC1){#supp2}). Activation of genes involved in UPR and ERAD was confirmed by real-time PCR ([Fig. 1 D](#fig1){ref-type="fig"}). In agreement with manual curation, inflammation appeared in the neuropathy at P28, as indicated by the strong enrichment of GO categories related to cytokine secretion (15-fold).

By 4 mo, the GO categories related to inflammation were most represented, such as antigen processing and presentation (12.5-fold) and immune response (3.2-fold; Fig. S1). The UPR was less prominent compared with P5 and P28, with a relative enrichment of threefold (unpublished data).

P0S63del is associated with down-regulation of the lipid synthesis program
--------------------------------------------------------------------------

The presence of P0S63del was also associated with down-regulation of a large number of genes. At P5, the down-regulation affected mainly genes encoding for enzymes involved in lipid metabolism, such as lanesterol synthase (*Lss*), Acyl-coA synthetase (*Acss2*), and farnesyl diphosphate farnesyl transferase 1 (*Fdft1*), and in transport, like the solute carriers *Slc15a2* and *Slc6a15* ([Table S2](http://www.jem.org/cgi/content/full/jem.20122005/DC1){#supp3}).

At P28 most of these genes were still down-regulated, but there was also a striking down-regulation of cytoskeletal genes, such as actin and myosin. At 4 mo, fewer genes were down-regulated, although primarily related to lipid metabolism and cytoskeletal reorganization (Table S2).

Application of L2L analysis to down-regulated genes identified the highest enrichment in GO categories related to lipid/sterol/cholesterol biosynthesis at all time-points ([Fig. 2 A](#fig2){ref-type="fig"} and [Fig. S2](http://www.jem.org/cgi/content/full/jem.20122005/DC1Fig){#supp4}). The down-regulation of the genes encoding for the key enzymes in cholesterol biosynthesis was confirmed via real-time qPCR ([Fig. 2 B](#fig2){ref-type="fig"}). Given that ∼70% of myelin is constituted by lipids, and the importance of cytoskeletal remodeling during myelination, these observations may be relevant to the hypomyelinating phenotype of S63del mice.

![**The lipid/cholesterol biosynthetic program is strongly down-regulated in S63del nerves.** (A) L2L analysis at P5 of genes down-regulated in S63del nerves identified an enrichment for GO categories related to lipid metabolism. (B) Quantitative RT-PCR for a selection of enzymes involved in the cholesterol biosynthetic pathway. Error bars, SEM; *n* = 4 RT from independent pools of nerves. \*, P \< 0.05, \*\*, P \< 0.01 by Student's *t* test; n.s. = not significant.](JEM_20122005R_Fig2){#fig2}

Surprisingly, the same down-regulation was not observed for myelin structural protein genes. The mRNAs encoding myelin basic protein (*MBP*) and peripheral myelin protein 22 (*PMP22*) were unchanged relative to WT, whereas the mRNAs for noncompact myelin components, such as Connexin32, Periaxin, and myelin-associated glycoprotein (*MAG*) were only mildly down-regulated (Table S2 and not depicted). Moreover, the transcription factor *Egr2/Krox20*, which is a key regulator of myelination ([@bib66]; [@bib62]) that drives synthesis of both myelin proteins and lipids ([@bib27]; [@bib39]) was expressed at levels comparable to WT ([Fig. 2 B](#fig2){ref-type="fig"}). Myelin protein and lipid synthesis is uncoordinated in S63del nerves, despite normal levels of Krox20.

UPR is a unique feature of S63del nerves
----------------------------------------

To address which transcriptional changes are mutation- and neuropathy-specific, we analyzed the transcriptome of P28 sciatic nerves from mice overexpressing P0wt at levels comparable to P0S63del (P0oe line 80.4; [@bib72]). P0oe mice manifest a hypomyelinating neuropathy, similar to S63del mice, but without signs of demyelination or onion bulbs. L2L analysis for up-regulated genes (listed in [Table S3](http://www.jem.org/cgi/content/full/jem.20122005/DC1){#supp5}) showed the highest enrichment for categories related to mRNA metabolism and processing ([Fig. S3](http://www.jem.org/cgi/content/full/jem.20122005/DC1){#supp6}). Some of these categories were enriched also in S63del nerves (unpublished data), indicating that P0 mRNA or protein overexpression perturbs general transcription. On the contrary, and confirming our previous observations ([@bib51]), P0oe nerves did not show an enrichment for genes related to UPR, suggesting that the ER stress is not caused by the overexpression of P0 by itself, but to the *Mp*zS63del mutation. Surprisingly, despite the fact that the P0oe nerves are hypomyelinated ([@bib72]), we did not see a significant down-regulation of genes related to lipid or cholesterol biosynthesis ([Table S4](http://www.jem.org/cgi/content/full/jem.20122005/DC1){#supp7}); the main down-regulation was for genes involved in cell growth and morphogenesis (Fig. S3), confirming that developmental hypomyelination in P0oe and S63del mice result from different pathomechanisms.

Collectively, these data confirm that the UPR is a specific feature of S63del nerves, which is already active as myelination begins, whereas inflammation and cell death are secondary effects of the neuropathy. In parallel, there is a significant increase in genes related to Schwann cell dedifferentiation, accompanied by a dramatic decrease in the levels of lipid/cholesterol synthetic genes ([Table 1](#tbl1){ref-type="table"}).

###### 

Summary of the main pathways dysregulated in S63del nerves

                            P5                                                            P-value     P28                                                                  P-value    4 mo                                  P-value
  ------------------------- ------------------------------------------------------------- ----------- -------------------------------------------------------------------- ---------- ------------------------------------- ----------
  Up-regulated pathways     UPR (stress)                                                  2.1e^-15^   UPR (stress)                                                         1.8e^-7^   Inflammation                          2.7e^-6^
                                                                                                      Cell death                                                           2.9e^-5^   Cell death                            4.4e^-4^
                                                                                                                                                                                      UPR (stress)                          2.1e^-3^
                            Early TF[a](#tblfn1){ref-type="table-fn"} (Oct6, Id2, Sox2)               Early TF[a](#tblfn1){ref-type="table-fn"} (Oct6, Id2, Sox2, c-Jun)              Early TF\* (Oct6, Id2, Sox2, c-Jun)   
  Down-regulated pathways   Lipid biosynthesis                                            1.4e^-35^   Lipid biosynthesis                                                   1.8e^-7^   Lipid biosynthesis                    8.9e^-4^
                            Sterol biosynthesis                                           5.6e^-28^   Sterol biosynthesis                                                  2.7e^-7^   Sterol biosynthesis                   4.7e^-3^
                            Cholesterol biosynthesis                                      3.0e^-26^   Cholesterol biosynthesis                                             1.6e^-4^   Cholesterol biosynthesis              6.6e^-3^

Results are based on manual categorization and L2L analysis.

Arbitrary category, not present in L2L or GO. For this reason, Early TF have no p-values.

Genes rescued in S63del/*Chop*-null mice
----------------------------------------

The UPR is a generally adaptive response that, in some circumstances, can become maladaptive. Ablation of the transcription factor *Chop* from S63del mice produced a complete rescue of the motor capacity, and the number of demyelinating fibers was halved ([@bib51]), indicating that CHOP plays a maladaptive role in CMT1B neuropathy. We have previously shown that *Chop*-null mice are morphologically and behaviorally identical to WT ([@bib51]). Accordingly, comparison of WT and *Chop*-null transcriptomes revealed very few differences ([Fig. 1 A](#fig1){ref-type="fig"} and [Table S5](http://www.jem.org/cgi/content/full/jem.20122005/DC1){#supp8}) that could obscure a comparison of S63del to S63del/*Chop*-null nerves.

Therefore, to identify a molecular basis for the rescue, we compared the transcriptomes of S63del and S63del/*Chop*-null nerves. A search for genes that were up-regulated in S63del versus WT (see above), and returned toward normal levels after the ablation of *Chop* revealed a total of 157 genes (24 at P5, 73 at P28, and 60 at 4 mo; [Table S6](http://www.jem.org/cgi/content/full/jem.20122005/DC1){#supp9}). However, there were no common genes among the three different time points, apart from CHOP itself. The P5 group was the smallest, suggesting the possibility that many targets of CHOP had not yet been activated by the neuropathic process. Moreover, most of the genes in this group were expressed at very low levels and were not expressed in the later time points (unpublished data), making it unlikely for them to have a role in the rescue. We also reasoned that at 4 mo, most of the rescued genes could be a consequence of secondary effects of the attenuated neuropathy. Hence, we focused on P28, where we identified 73 genes that were significantly less up-regulated in the absence of CHOP (Table S6). To choose those that were more likely to be targets of CHOP, we injected P28 WT and *Chop*-null mice with tunicamycin, a potent activator of the UPR, and performed transcriptomic analysis on sciatic nerves harvested after 48 h, when CHOP mRNA was up-regulated to a level similar to that seen in P28 S63del nerves (by real-time qPCR; unpublished data). Surprisingly, the transcriptional alteration caused by tunicamycin injection in WT mice was much broader than the one caused by the chronic expression of S63del. More than 1,000 genes were up-regulated at least 1.5-fold by tunicamycin compared with the 509 up-regulated in P28 S63del nerves ([Fig. 3 A](#fig3){ref-type="fig"}). Of these, 103 were up-regulated in common, and L2L analysis confirmed that they were mainly stress-related genes ([Fig. S4](http://www.jem.org/cgi/content/full/jem.20122005/DC1){#supp10} and not depicted). Finally, we examined how many of these 103 genes returned toward WT levels in both the nerves from S63del/*Chop*-null and tunicamycin-injected *Chop*-null mice. The result was eight genes (excluding CHOP itself), which are all candidate CHOP target genes ([Fig. 3 B](#fig3){ref-type="fig"}).

![**Gadd34 is a target of CHOP in S63del nerves.** (A) A Venn diagram of genes up-regulated both in sciatic nerves from P28 WT mice injected with tunicamycin and from P28 S63del mice identified 103 genes in common. Of these, nine returned to WT levels in *Chop*-null mice injected with tunicamycin and in S63del/*Chop*-null nerves. (B) Expression of CHOP and the eight CHOP target genes. Exp. Levels = raw level of expression in S63del nerves.](JEM_20122005_Fig3){#fig3}

The gene *Myd116/Gadd34* was the most interesting in the group. It was expressed most highly, and in support of our data, it had been shown to be a target of CHOP in cultured cells treated with tunicamycin ([@bib34]). Real-time qPCR analysis confirmed that Gadd34 mRNA was up-regulated ∼2.5-fold in S63del and returned to near normal levels in S63del/*Chop*-null nerves ([Fig. 4 A](#fig4){ref-type="fig"}). Gadd34 is the activating subunit of the PP1--phosphatase complex that dephosphorylates eIF2α and reverses translational attenuation in the context of UPR ([@bib44]). Western blot analysis showed that the lack of up-regulation of Gadd34 protein in S63del/*Chop*-null ([Fig. 4, B and C](#fig4){ref-type="fig"}) resulted in a sustained up-regulation of eIF2α phosphorylation compared with S63del ([Fig. 4, B and D](#fig4){ref-type="fig"}).

![**Reduction of Gadd34 levels results in increased eIF2α phosphorylation.** (A) Quantitative RT-PCR for Gadd34 mRNA from P28 sciatic nerves. Error bars, SEM; \*, P \< 0.05; *n* = 4 RT from independent pools of nerves. (B) Western blot analysis on P28 sciatic nerve lysates was performed for Gadd34 and phosphorylated eIF2α; β-tubulin provides a control for loading. One representative experiment of four is shown. Numbers indicate relative molecular weights. (C) Gadd34 and (D) phosphorylated eIF2α protein levels as determined by densitometry. Error bars, SEM; \*\*, P \< 0.01, \*\*\*, P \< 0.001; *n* = 4.](JEM_20122005_Fig4){#fig4}

Could this difference in Gadd34 activation contribute to the beneficial effects of *Chop* deletion in the S63del mice? Phosphorylation of eIF2α blocks general protein translation but activates translation of specific mRNAs, such as ATF4 and Gadd34 itself ([@bib18]; [@bib28]). We hypothesized that the relative increase in P-eIF2α in S63del/*Chop*-null nerves would limit reactivation of translation that, in turn, could reduce the load of misfolded P0S63del in the ER, a benefit for the Schwann cell.

Inactivation of Gadd34 rescues the S63del phenotype
---------------------------------------------------

To further investigate the role of *Gadd34*, we crossed S63del mice with mice in which the Gadd34 protein lacks the domain that interacts with the catalytic unit of PP1c phosphatase ([@bib45]), which acts on P-eIF2α. *Gadd34*^Δc/Δc^ mice are healthy and fertile, manifested normal motor capacity ([Fig. 5 A](#fig5){ref-type="fig"}), and no morphological abnormality when compared with WT sciatic nerve (not depicted).

![**Inactivation of Gadd34 restores motor function and ameliorates the neurophysiological and morphological deficits in S63del mice.** (A) Rotarod analysis of motor function in WT, *Gadd34*^Δc/Δc^, S63del and S63del/*Gadd34*^Δc/Δc^. Error bars, SEM; \*, P \< 0.05; \*\*, P \< 0.01 for S63del/*Gadd34*^Δc/Δc^ relative to S63del; *n* = 20--25 animals. (B and C) Electrophysiological analysis showing NCV and F-wave latency; *n* = 10--12 animals; \*, P \< 0.05; \*\*, P \< 0.01, relative to S63del by Student's *t* test. NCV, nerve conduction velocity. (D) Semithin sections stained with toluidine blue from P28 and P180 WT, S63del, and S63del/*Gadd34*^Δc/Δc^ sciatic nerves. Arrows, amyelinated axons in P28 S63del nerve. Arrowhead, demyelinated fiber/onion bulb in 6-mo-old S63del nerve. Bar, 10 µm. (E) Number of amyelinated axons at P28, and of demyelinated fibers (F) and onion bulbs (G) at 6 mo. Error bars, SEM; \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001, by Student's *t* test; *n* = 20--35 microscopic fields from 4--6 animals per genotype.](JEM_20122005_Fig5){#fig5}

S63del mice show reduced motor capacity as measured by the rotarod test. The genetic ablation of *Chop* was able to rescue the motor deficit ([@bib74]; [@bib51]). Therefore, we asked whether the inactivation of *Gadd34* could have a similar effect. Rotarod analysis on 4-mo-old mice showed that S63del/*Gadd34*^Δc/Δc^ mice regained normal motor capacity ([Fig. 5 A](#fig5){ref-type="fig"}). In S63del/*Chop*-null mice, the motor rescue was accompanied by a reduction by half in demyelinating fibers, a small reduction in onion bulbs, and a rescue in F-wave latency, despite the fact that NCV remained impaired ([@bib51]). The rescue after *Gadd34* inactivation from S63del mice was strikingly more extensive: nerve conduction velocities (NCVs) improved from 33.6 ± 0.9 m/s in S63del to 37.4 ± 0.9 m/s in S63del/*Gadd34*^Δc/Δc^, and F-wave latency returned to almost WT levels ([Fig. 5, B and C](#fig5){ref-type="fig"}). Moreover, morphological rescue was more complete. P28 S63del nerves show a significant number of amyelinated axons, which are larger than 1 mm in diameter and in 1:1 relationship with a Schwann cell but do not have a myelin sheath. Inactivation of *Gadd34* resulted in a fivefold reduction of these fibers ([Fig. 5 E](#fig5){ref-type="fig"}). Finally, in 6-mo-old mice, the lack of Gadd34 activity produced a significant reduction in both demyelinated fibers and in onion bulbs ([Fig. 5, F and G](#fig5){ref-type="fig"}).

The reduction in amyelinated axons in P28 nerves prompted us to perform a morphometric analysis to measure myelin thickness. In fact, it appeared that whereas ablation of *Chop* had little effect on the hypomyelination phenotype of S63del mice ([@bib51]), the inactivation of *Gadd34* might have a positive effect. Indeed, hypomyelination was improved, as measured by g-ratio, at both P28 and 6 mo ([Fig. 6, A and B](#fig6){ref-type="fig"}), although it did not return fully to WT levels. Interestingly, the g-ratio rescue was more evident in small-caliber axons, whereas the axonal numbers and distribution appeared to be normal among the genotypes (g-ratio scatterplots and histograms of axonal diameter are available upon request). An improvement in myelin thickness should result in an increased amount of myelin proteins in bulk myelin. Accordingly, Western analysis showed a significant increase in MBP in S63del/*Gadd34*^Δc/Δc^ as compared with S63del nerves, and a small increase also in the amount of PMP22, whereas MAG, a component of noncompact myelin, was not increased ([Fig. 6, C--E](#fig6){ref-type="fig"}).

![**Inactivation of Gadd34 ameliorates the hypomyelination in S63del mice.** (A) Semithin sections stained with toluidine blue from P28 and P180 WT, S63del, and S63del/*Gadd34*^Δc/Δc^ sciatic nerves. Bar, 20 µm. (B) G-ratios in 6-mo old nerves. \*\*, P \< 0.01, relative to S63del, by Student's *t* test; 8--10 microscopic fields per mouse were analyzed, from 5 mice per genotype. (C) Western blot analysis was performed on sciatic nerve lysates for the myelin proteins MAG, PMP22, and MBP. Numbers indicate relative molecular weights. One representative experiment of three is shown. (D) MBP and (E) PMP22 protein levels as measured by densitometric analysis and E. Error bars, SEM; \*\*, P \< 0.01; *n* = 3 repeat blots.](JEM_20122005_Fig6){#fig6}

Inactivation of Gadd34 limits reactivation of translation in S63del nerves
--------------------------------------------------------------------------

Gadd34 acts to reverse translational attenuation caused by eIF2α phosphorylation during ER stress. Western blot analysis showed that inactivation of *Gadd34* in S63del nerves significantly increased eIF2α phosphorylation and, as a consequence, the level of ATF4 ([Fig. 7, A and B](#fig7){ref-type="fig"}). We therefore hypothesized that blocking Gadd34 activity would keep translation attenuated, reducing the toxicity associated with expression of high levels of P0S63del. To measure this directly, we explanted sciatic nerves in culture and performed metabolic labeling of total protein synthesis. Accumulation of labeled proteins proceeded linearly for at least 2 h after nerve dissection (unpublished data), whereas adding an agent (DTT) that elicited a strong UPR nearly completely blocked translation ([Fig. 7 C](#fig7){ref-type="fig"}). Metabolic labeling of total protein showed a ∼20% reduction in S63del, and a more pronounced 35--40% reduction in S63del/*Gadd34*^Δc/Δc^ as compared with WT nerves ([Fig. 7, C and D](#fig7){ref-type="fig"}). S63del/*Chop*-null nerves also translated fewer proteins than the S63del, but more than the S63del/*Gadd34*^Δc/Δc^ nerves ([Fig. 7, E and F](#fig7){ref-type="fig"}), consistent with the existence of CHOP-independent activation of Gadd34 expression ([@bib34]).

![**Increased translational attenuation in S63del/*Gadd34*^Δc/Δc^ nerves.** (A) Western blot analysis on P28 sciatic nerves for phosphorylated eIF2α and ATF4. Numbers indicate relative molecular weights. One representative experiment of five is shown. (B) Phosphorylated eIF2α levels, as measured by densitometric analysis. Error bars, SEM; *n* = 5 repeat blots. (C) Measurement of newly synthesized proteins via S^35^ incorporation (metabolic labeling) in explanted P28 WT, S63del, and S63del/*Gadd34*^Δc/Δc^ sciatic nerves. (E) Metabolic labeling measuring newly synthesized proteins in explanted sciatic nerves from P28 WT, *Chop*-null, and S63del/*Chop*-null nerves. 1 representative blot of 10 is shown for each experiment. (D and F). Quantification of newly synthesized proteins (via S^35^ incorporation) by densitometric analysis. (F) Error bars, SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001, n.s., not significant, by Student's *t* test; *n* = 10 independent experiments.](JEM_20122005R_Fig7){#fig7}

Less protein synthesis would be predicted to lower the load of unfolded proteins in the ER of the S63del/*Gadd34*^Δc/Δc^ compared with the S63del nerves and lead to a commensurate reduction in UPR activity. Accordingly, immunostaining of teased fibers from S63del and S63del/*Gadd34*^Δc/Δc^ sciatic nerves showed that in the absence of Gadd34 activity, P0S63del accumulates much less in the perinuclear area of Schwann cells ([Fig. 8 A](#fig8){ref-type="fig"}). This is further supported by real-time PCR analysis for markers of the UPR that showed, as early as P28, a significant reduction in BiP mRNA and in Xbp-1 splicing in S63del/*Gadd34*^Δc/Δc^ compared with S63del ([Fig. 8, B and C](#fig8){ref-type="fig"}). Moreover, Western analysis showed that BiP protein is lower in 6-mo-old S63del/*Gadd34*^Δc/Δc^ compared with S63del nerves, and this was paralleled by a significant decrease in the cleaved form of ATF6. Therefore, all three arms of the UPR ([@bib55]) are less active, consistent with a general reduction in ER stress in S63del nerves lacking Gadd34 activity.

![**Attenuation of ER stress in S63del/*Gadd34*^Δc/Δc^ nerves.** (A) Immunostaining of teased fibers reveals P0 (green) staining in the perinuclear area (arrowheads) of S63del Schwann cells; nuclei were stained with DAPI (blue). *n* = 3 mice per genotype were analyzed. Bar, 10 µm. (B and C) mRNA levels for BiP and spliced Xbp-1 were measured by quantitative RT-PCR in P28 sciatic nerves. Error bars, SEM. \*, P \< 0.05; \*\*, P \< 0.01, Student's *t* test, *n* = 6 RT from independent pools of nerves (D and E) Western blot analysis on sciatic nerve lysates for BiP and ATF6. Arrowheads in E indicate the 90-kD precursor and the 50-kD active form of ATF6. Numbers indicate relative molecular weights. One representative experiment of four is shown.](JEM_20122005_Fig8){#fig8}

eIF2α phosphorylation as a therapeutic target
---------------------------------------------

The effective rescue of the CMT1B phenotype by *Gadd34* inactivation, suggested it could be a therapeutic target. Salubrinal is a recently identified small molecule that inhibits the Gadd34-mediated dephosphorylation of eIF2α ([@bib7]). To provide proof of principle for salubrinal as a therapeutic agent, we took advantage of myelinating dorsal root ganglia (DRG)--explant cultures. S63del DRG explant cultures myelinate 80% less than WT DRG explant cultures ([Fig. 9 A](#fig9){ref-type="fig"}). Salubrinal is known to be toxic in some contexts, and accordingly, treatment of WT DRG cultures with salubrinal reduced myelination, but by \<80% ([Fig. 9 B](#fig9){ref-type="fig"} and not depicted). However, at concentrations between 20 and 40 µM, salubrinal significantly improved myelination in S63del DRG cultures, as measured by the number of MBP-positive internodes ([Fig. 9, A and C](#fig9){ref-type="fig"}). Strikingly, at these concentrations of salubrinal, the number of internodes in S63del was very similar to WT, suggesting an almost complete rescue, whereas at higher concentrations, salubrinal appeared to be toxic also in S63del DRG cultures ([Fig. 9 C](#fig9){ref-type="fig"}). CMT1B associated with P0S63del manifests both developmental hypomyelination (amyelinated fibers from early in development), and even more predominant adult demyelinating neuropathy (myelin destruction and onion bulbs; [@bib35]), but demyelination is poorly represented in DRG-explant cultures. Therefore, to evaluate the effect of salubrinal on demyelinating neuropathy, we treated S63del mice, starting at P30, when myelination is nearly complete, and then measured motor capacity at 4 mo (90 d of treatment) and morphology and electrophysiology at 6 mo (150 d of treatment). Strikingly, S63del mice treated with salubrinal regained almost normal motor capacity in rotarod analysis ([Fig. 9 D](#fig9){ref-type="fig"}), and this was accompanied by a rescue of morphological and electrophysiological abnormalities. In particular, demyelinated fibers and onion bulbs were significantly reduced as compared with S63del treated with vehicle ([Fig. 9, E--G](#fig9){ref-type="fig"}). Moreover, both NCV and F-wave latency were significantly ameliorated in salubrinal-treated S63del nerves ([Fig. 9, H and I](#fig9){ref-type="fig"}). In contrast, little amelioration was observed in the hypomyelination of S63del nerves ([Fig. 9 E](#fig9){ref-type="fig"} and not depicted), consistent with the fact that the treatment started when myelination was nearly complete. These data suggest that targeting eIF2α phosphorylation could be a therapeutic strategy for neuropathies related to misfolded proteins.

![**Salubrinal improves myelination in S63del DRG explant cultures and reduces demyelination in S63del mice.** (A) Dorsal root ganglia (DRG) were dissected from E14 WT and S63del embryos and myelination was induced with 50 µg/ml ascorbic acid. Myelin internodes were detected with antibodies against MBP (red). Nuclei were visualized with DAPI (blue). Bar, 100 µm. (B and C) Number of myelinating internodes in WT and S63del DRG treated for 3 wk with salubrinal at the indicated concentrations; *n* = 25--50 fields from 6--8 DRG per condition. Error bars, SEM; \*\*, P \< 0.01; \*\*\*, P \< 0.001. (D) Rotarod analysis of WT and S63del mice treated for 90 d with either salubrinal (Sal) or vehicle (V). Error bars, SEM; *n* = 12 mice per condition. (E) Semithin sections stained with toluidine blue from P180 sciatic nerves from WT and S63del mice treated with either vehicle (V) or salubrinal (Sal) for 150 d. S63del nerves show several demyelinated fibers (arrowhead) and onion bulbs (arrow). Nerves from 10 mice per genotype were analyzed; bar, 10 µm. (F--G) Percentage of onion bulbs and demyelinated fibers in sciatic nerves from 6-mo-old S63del mice treated with Sal for 150 d. Error bars, SEM; \*, P \< 0.05; \*\*, P \< 0.01 by Student's *t* test. 8 microscopic fields from each mouse were analyzed, *n* = 10 mice per condition. (H and I). Electrophysiological analysis of NCV and F-wave latency in 6-mo-old mice (150 d of treatment with Sal or vehicle). Error bars, SEM; \*\*\*, P \< 0.001; n.s. = not significant by Student's *t* test. *n* = 12--18 nerves per condition.](JEM_20122005R_Fig9){#fig9}

DISCUSSION
==========

We showed previously that the CMT1B mutant P0S63del is retained in the ER of myelinating Schwann cells where it elicits a dose-dependent UPR. Ablation of *Chop* partially rescues the demyelination ([@bib51]; [@bib74]), indicating that the PERK/CHOP arm of the UPR is pathogenetic in this context. In the last decade, the transcriptomes of PNS myelination, axonal degeneration/regeneration, and neuropathy have revealed complex molecular mechanisms and several interesting signaling pathways, but not a direct link with nerve pathology ([@bib1]; [@bib24]; [@bib40]; [@bib70]; [@bib15]; [@bib9]; [@bib26]; [@bib6]; [@bib65]; [@bib20]). Here, through transcriptomic and bioinformatic analysis, we show that the activation of a UPR is the earliest and predominant molecular event in the P0S63del neuropathy, and identify the gene *Gadd34* as an important pathogenetic target of CHOP. Accordingly, inactivation of *Gadd34* in S63del mice ameliorates the CMT phenotype more effectively than ablation of *Chop*, resets translational homeostasis toward attenuation, and reduces accumulation of P0S63del in the ER of Schwann cells. Finally, we show that the eIF2α--Gadd34 interaction can be pharmacologically targeted to improve myelination in S63del DRG-explants and mice. Although *Gadd34* is a target of CHOP in cultured cells treated with tunicamycin ([@bib34]), this is the first time to our knowledge that it has been shown to be regulated by CHOP in an authentic disease model.

The PERK-CHOP arm of the UPR is pathogenetic in S63del mice
-----------------------------------------------------------

Transcriptomic analysis of CMT1B nerves confirmed and expanded our previous observation that the UPR induced by ER retention of P0S63del is pathogenetic ([@bib51]). First, the UPR was dramatically activated very early in development, in association with hypomyelination. The transcriptional profile of Schwann cells in S63del nerves revealed that by P5, and persisting through to P28, the largest changes were in pathways related to the response to unfolded protein, as well as to protein folding and degradation. Instead genes and pathways related to inflammation and cell death become prominent only later, after the peak of myelination, and likely reflect secondary events in the neuropathy. Second, the UPR is persistent throughout the life of S63del animals in association with later demyelination. Third, the activation of the UPR requires the P0 mutation. The transcriptome of nerves from transgenic mice that overexpress P0wt at levels similar to P0S63del ([@bib72]) did not reveal any increase in genes related to ER stress. Fourth, the UPR has been identified in other demyelinating neuropathies, including a mouse model of the P0R98C mutation which causes congenital hypomyelination in humans ([@bib57]) and in the PMP22 Trembler (*Tr or TrJ*) mouse where an increase of some stress response genes, such as Hsp1a and Hsp1b (*Tr*; [@bib15]), as well as UPR (*TrJ*; Khajavi, M., and Lupski, J.R., personal communication) have been detected, probably related to the impaired intracellular trafficking and misfolding of the mutant PMP22 proteins ([@bib12]; [@bib38]). The UPR is not only closely associated with neuropathy, but in the context of a misfolding-prone P0 mutation, ablation of UPR target genes *Chop*, and even more so *Gadd34*, had a strong salutary effect on the associated neuropathy. Thus, comprehensive expression and functional analysis indicate that the UPR, the PERK pathway in particular, is pathogenetic in neuropathy associated with protein misfolding in the ER of Schwann cells.

The microarray analysis of CMT1B nerves suggests that the sustained activation of the PERK/CHOP arm of the UPR does not primarily result in Schwann cell death in S63del nerves ([@bib56]; [@bib51]). In fact, we did not detect a significant increase in apoptotic genes until 4 mo after birth. Moreover, the known effectors of ER stress--related cell death such as Bax, Bak, and caspase-12 ([@bib41]; [@bib71]; [@bib55]) are not significantly induced in S63del nerves. These observations further support the observation that the detrimental effects of persistent PERK activation through CHOP are context dependent ([@bib17]).

CHOP targets translational homeostasis in CMT1B nerves through Gadd34
---------------------------------------------------------------------

The immediate consequence of PERK activation in the UPR is to attenuate translation through phosphorylation of eIF2α, whereas protein folding and degradation capacity increase ([@bib60]; [@bib55]; [@bib3]). This is followed by induction of a feedback mechanism via eIF2α/ATF4/CHOP/Gadd34 by which translation is reactivated. Gadd34 is the regulatory subunit of the PP1 phosphatase complex that dephosphorylates eIF2α to reactivate translation in UPR ([@bib44]; [@bib23]), and this occurs also in S63del nerves.

However, by favoring lower levels of phosphorylated eIF2α, Gadd34 enhances the burden of unfolded proteins, which can be detrimental in persistent ER stress conditions. For example, *Gadd34*-null cells in culture are more resistant to ER stress ([@bib34]). Here, we show in S63del neuropathy, an authentic model of CMT1B, that Gadd34 is detrimental, as myelination improves in S63del/*Gadd34*^Δc/Δc^ nerves. Moreover, we identify the beneficial effect in S63del/*Gadd34*^Δc/Δc^ Schwann cells, as the accumulation of mutant P0S63del in their ER was clearly reduced ([Fig. 8 A](#fig8){ref-type="fig"}).

This also provides further evidence that myelinating cells are particularly sensitive to alterations in translation, especially relating to eIF2 regulation ([@bib10]; [@bib29]). By dephosphorylating eIF2α, Gadd34 promotes the GTP exchange by eIF2B on eIF2. Not only does Gadd34 moderate CMT1B neuropathy in the PNS, and interferon-γ--induced demyelination in the CNS ([@bib31]), but also mutations in various subunits of eIF2B cause vanishing white matter disease in the CNS, which is often associated with diffuse oligodendrocyte death ([@bib69]).

We hypothesize that the excessive load of misfolded protein in the ER of S63del Schwann cells is a direct consequence of Gadd34 reactivation of translation too aggressively toward normal rates. Directly inactivating *Gadd34*, or diminishing its up-regulation as in S63del/*Chop*-null mice, maintains an intermediate level of eIF2α phosphorylation that limits the reactivation of translation ([@bib34]) and achieves a better compromise between the load of misfolded protein and the need for translation to produce and maintain myelin. Accordingly, we found that in both S63del/*Chop*-null and S63del/*Gadd34*^Δc/Δc^ nerves, eIF2α phosphorylation was significantly higher than in S63del nerves, and global protein translation was reduced as compared with S63del ([Fig. 7](#fig7){ref-type="fig"}). In particular, in S63del/*Gadd34*^Δc/Δc^ mice, the accumulation of mutant P0S63del in the Schwann cell ER was clearly reduced ([Fig. 8 A](#fig8){ref-type="fig"}). Finally, we detected a reduction in UPR markers such as BiP chaperone, spliced Xbp-1 and active ATF6, indicating less ER stress ([Fig. 8](#fig8){ref-type="fig"}).

*Gadd34* versus *Chop* inactivation in S63del myelination
---------------------------------------------------------

In S63del mice, the inactivation of *Gadd34* more effectively rescues myelination than ablation of *Chop*, indicating that Gadd34 is more detrimental in S63del Schwann cells. As with *Chop* ablation ([@bib51]), we found restoration of the motor capacity to WT levels, and a remarkable reduction in the number of demyelinated fibers. However, in S63del/*Gadd34*^Δc/Δc^ mice we also found a significant improvement in nerve conduction velocity, a reduction in onion bulb formation, and a more substantial amelioration of the hypomyelinating phenotype, as measured by the number of amyelinated axons, g-ratio, and myelin protein levels, both at P28 and in the adult.

Possible explanations for this difference include that the block in global protein synthesis remains more pronounced with inactivation of *Gadd34* ([Fig. 7](#fig7){ref-type="fig"}; [@bib34]), whereas ablation of *Chop* impedes Gadd34 up-regulation, but the remaining basal level of Gadd34 activity could still partially dephosphorylate eIF2α and reactivate translation. Alternatively, inactivation of *Gadd34* may more directly correct the imbalance within the program of myelin proteins and lipids that led to dysmyelination and demyelination Dosage of genes encoding myelin proteins and their stoichiometry in compact myelin are very precisely regulated in normal myelination ([@bib59]). Finally, although *Gadd34* is a maladaptive target of *Chop* in S63del Schwann cells, CHOP mediates a balance of both maladaptive and adaptive targets. For example, derlin-3 is significantly less up-regulated in S63del/*Chop*-null compared with S63del nerves ([Fig. 3](#fig3){ref-type="fig"}), and derlin-3 is a component of a complex that functions in ER-associated degradation (ERAD) of misfolded proteins---an adaptive role of the UPR ([@bib46]). Thus, impairing *Chop* may remove not only maladaptive, but also adaptive effectors and produce a less complete rescue of myelination. This idea is particularly appealing because it could explain the context-dependent behavior of CHOP ([@bib17]), that is detrimental in Schwann cells ([@bib51]), but beneficial in oligodendrocytes in a model of Pelizeus-Merzbacher disease ([@bib61]). The balance of adaptive and maladaptive CHOP targets may simply differ between the two cell types.

UPR-limited Schwann cell differentiation as an adaptive strategy in S63del neuropathy
-------------------------------------------------------------------------------------

Limited differentiation is likely to be adaptive in S63del Schwann cells, as P0 is the most abundant terminal differentiation product in myelinating Schwann cells (8% of mRNA and \>20% of protein). Moreover increasing the dose of P0S63del also increases activation of the UPR ([@bib51]). Therefore, we speculate that altering translational homeostasis through Gadd34 manipulation reduces the level of the misfolded P0S63del, whereas permitting a slow rate of accumulation of P0wt in myelin and some myelin associated function (note that CMT1B is a dominant disease where both a misfolded and a normal version of P0 are synthesized). This idea is nicely supported by the observation that less total P0 accumulates in the perinuclear region of S63del/*Gadd34*^Δc/Δc^-teased fibers, and this probably represents P0S63del because P0wt is not detected by immunofluorescence in the same area of WT-teased fibers. In support of our speculation, limited differentiation may play an adaptive role in other cells where misfolded proteins include terminal differentiation products (e.g., collagen in chondrocytes; [@bib67]).

Interestingly, we identified other examples of limited terminal differentiation in S63del Schwann cells. However, their effects may be detrimental. For example, in all time points analyzed, we found a remarkable down-regulation of genes and pathways related to lipid and cholesterol biosynthesis, previously reported also in other hypomyelination neuropathies ([@bib15]). The UPR may directly interfere with the lipid synthesis program as both ATF6 and sterol regulatory element binding protein 2 (SREBP2) transcription factors are activated via proteolytic cleavage by S1P and S2P proteases in the Golgi, and it has been recently proposed that conditions of stress that activate ATF6 also suppressed SREBP2 activity ([@bib76]). We also found up-regulation of early Schwann cell transcription factors, such as Oct6, Id2, Sox4, Sox2, and c-Jun in S63del nerves. Some of these factors, in particular c-Jun, Sox2, and Id2, have been suggested to act as negative regulators of myelination ([@bib26]; [@bib33]; [@bib49]).

Pharmacological targeting of eIF2α
----------------------------------

Protein quality control is a potential therapeutic target in myelin diseases. Autophagy, stimulated via fasting or rapamycin, or an increase in the heat shock response, can improve the phenotype of some PMP22-related neuropathies ([@bib13]; [@bib53], [@bib54]; [@bib32]), and salubrinal enhancement of the integrated stress response (ISR) ameliorated hypomyelination and oligodendrocyte loss in cultured hippocampal slices exposed to IFN-γ ([@bib31]).

We have shown here that Gadd34 is detrimental in S63del nerves, and that its inhibition could be an effective therapeutic strategy. Salubrinal blockade of eIF2α dephosphorylation significantly improves hypomyelination in S63del DRG explants. More importantly, it restores motor function and ameliorates morphological and electrophysiological parameters of demyelination in S63del mice. Unfortunately, treatment with salubrinal reduced motor capacity in WT mice. However, the normal morphology and electrophysiology in these mice suggest that poor rotarod performance may be caused by an effect outside of nerve, on muscle for example.

Salubrinal has also been successfully used in a model of ALS to reset homeostasis in motor neurons with SOD1 mutations ([@bib58]). However, a note of caution is raised by prion-induced neurodegeneration, where Gadd34 overexpression is protective and salubrinal treatment in mouse models actually impairs neuronal survival ([@bib37]). Finally, compounds like guanabenz may provide less toxic alternatives for modulation of eIF2α phosphorylation in animal models of disease ([@bib68]).

Relevance for neuropathy and other misfolded protein diseases
-------------------------------------------------------------

Mutations in \>30 genes account for about one-half of CMT hereditary neuropathies ([@bib73]; [@bib59]), but the pathomechanisms are still poorly understood and at present there is no cure. ER retention of CMT-related mutant proteins is not unique to P0S63del; we have identified at least five other P0 mutants that are retained in the ER and elicit a UPR ([@bib51]; [@bib57]), and protein misfolding and altered trafficking have been implicated in the pathogenesis of other CMT neuropathies as a result of mutations in PMP22 and Cx32 ([@bib8]; [@bib22]; [@bib75]). Moreover, protein misfolding and ER stress have been associated with various diseases, ranging from neurodegenerative diseases (Alzheimer disease, Parkinson disease, and ischemic insults) to cancer and diabetes, suggesting that this study may have broad therapeutic implications.

MATERIALS AND METHODS
=====================

### Animals.

All experiments involving animals were performed in accord with experimental protocols approved by the San Raffaele Scientific Institute Animal Care and Use Committee. P0S63del transgenic mice ([@bib74]), P0-overexpressing (oe) mice (line 80.4; [@bib72]), *Chop*-null mice ([@bib77]), and *Gadd34*^Δc/Δc^ mice ([@bib45]) have been described previously. P0S63del, P0oe, and *Chop*-null mice were maintained on the FVB/N background, whereas *Gadd34*^Δc/Δc^ mice, initially on a C57BL/6 background, were backcrossed for at least six generations onto the FVB/N background before initiation of experiments. In all the experiments, littermates were used as controls.

### Tunicamycin and salubrinal injections.

Where indicated, WT and *Chop*-null mice were injected i.p. with 1 mg tunicamycin/g body weight, in 150 mM dextrose. 48 h later, mice were killed by CO~2~ inhalation, and sciatic nerves were harvested for RNA preparation. Salubrinal (Tocris) was reconstituted at 2 mM in PBS, 0.1% BSA with 10% DMSO, and i.p injected every alternate day for 150 d (P30--P180) at 1 mg/kg of body weight.

### RNA extraction and hybridization of arrays.

Total RNA from at least 15 (P5) or 10 (P28 or 4 mo) desheathed sciatic nerves for each of WT, *Chop*-null, S63del, S63del/*Chop*-null mice; from 5 desheathed sciatic nerves from WT and *Chop*-null, tunicamycin-injected mice; and 10 sciatic nerves from P0oe mice were extracted using TRIzol (Roche) and purified with RNeasy kit (QIAGEN), as previously described ([@bib9]). Biotin-labeled cRNA targets were synthesized starting from 5 µg of total RNA. RNA quality was tested with an Agilent Bioanalyzer. Double-stranded cDNA synthesis was performed with Gibco SuperScript Custom cDNA Synthesis kit, and biotin-labeled antisense RNA was transcribed in vitro using Ambion's in vitro Transcription System, including Bio-11-UTP and Bio-11-CTP (PerkinElmer) in the reaction. All steps of the labeling protocol were performed as suggested by Affymetrix. The size and the accuracy of quantitation of targets were confirmed by agarose gel electrophoresis of 2 mg aliquots, before and after fragmentation. After fragmentation, targets were applied to Affymetrix Mouse GeneChipMOE430A 2.0. Two replicates for each genotype at each time point were prepared from completely independent pools of nerves (biological replicas).

### Data Analysis.

Images were scanned with an Affymetrix GeneChip Scanner3000 7G, using default parameters. The resulting images were analyzed using GeneChip Operating Software v1.4 (GCOS1.4). Report files were extracted for each chip, and performance of labeled targets was evaluated on the basis of several values (scaling factor, background and noise levels, percentage of present calls, average signal value, 5′-3′ values). Data were then imported onto GeneSpring (Agilent) and Partek for further analysis.

Average signal intensity of transcripts from WT nerves was used to normalize the corresponding signal intensity in all other conditions. Replicate experiments were highly reproducible, with pairwise correlation coefficients mostly ranging from 0.95 to 0.99. Genes that had a correlation coefficient \<0.95 were eliminated. Taking into account that CHOP mRNA had signal intensity of ∼80--100 in the *Chop*-null extracts, genes with a signal intensity value \<100 in all the genotypes were discarded.

Starting from this gene list, a selection of regulated transcripts in comparison to the WT baseline was performed with the fold-change cutoff set to 1.5. Only a few genes were different between WT and *Chop*-null, and therefore we considered them to be identical. We focused our attention on genes that were up- or down-regulated in S63del as compared with WT and then examined whether or not they returned toward WT levels in S63del/*Chop*-null nerves. All of the gene-lists created (Tables S1--S6) were then loaded onto L2L software to search for enriched GO categories (binomial p-value test; P \< 0.05). Data combined with experimental information in MIAME compliant format have been submitted to Gene Expression Omnibus (GEO, accession no. [GSE40610](GSE40610)).

### TaqMan quantitative PCR analysis.

Total RNA was prepared as described above, and reverse transcription was performed as described previously ([@bib74]). Quantitative PCR was performed on an ABI PRISM 7700 sequence detection system (Applied Biosystems Instruments) according to the manufacturer's instructions (TaqMan; Applied Biosystems). The relative standard curve method was applied using WT mice as reference. Normalization was performed using either 18S rRNA or phosphoglycerate 1 (*Pgk1*) as reference genes. Target and reference gene PCR amplification were performed in separate tubes with Assays on Demand (Applied Biosystems Instruments): 18s, Hs99999901_s1; Pgk1, Mm00435617_m1; Ddit3/Chop, Mm00492097_m1; Myd116/Gadd34, Mm00435119_m1; ATF4, Mm00515324_m1; ATF3, Mm00476032_m1; Xbp-1u, Mm00457357_m1; Xbp-1s, Mm03464496_m1; Derl2, Mm00504288_m1; Derl3, Mm00508292_m1; Ero1b, Mm00470754_m1; Dnajc3/p58ipk, Mm01226332_m1; Hspa5/BiP, Mm00517691_m1; Ppp1r15b/CReP, Mm00551747_m1; Sdf2l1, Mm00452079_m1; Snx6, Mm00459049_m1; Snx16, Mm00511049_m1; Fdft1, Mm00815354_s1; Hmgcr, Mm01282499_m1; Hmgcs2, Mm00550050_m1; Mvd, Mm00507014_m1; Sqle, Mm00436772_m1; Egr2/Krox20, Mm00456650_m1; Pou3f1/Oct6, Mm00843534_s1; Sox2, Mm00488369_s1; Sox4, Mm00486320_m1; Id2, Mm00711781_m1; c-Jun, Mm00495062_s1.

### Western blot.

Sciatic nerves from WT and transgenic mice were dissected and immediately frozen in liquid nitrogen. Proteins were extracted and analyzed as previously described ([@bib72]). Mouse monoclonal antibodies recognized β-tubulin (1:500; Sigma-Aldrich), ATF6 (1:1,000; Imgenex,), MBP (1:5,000; Covance), and MAG (1:1,000; EMD Millipore). Rabbit polyclonal antibodies recognized Grp78/BiP (1:1,000; Stressgen), ATF4 (1:500; Santa Cruz Biotechnology), phosphorylated eIF2α (Ser51; 1:500; Cell Signaling Technology), PMP22 (Abcam), eIF2α (1:1,000; the anti-serum was raised in a rabbit injected with purified mouse eIF2α \[peptide 1--185\] produced as a HisX6 fusion protein in *E. coli*), and Gadd34 ([@bib45]). Peroxidase conjugated anti--mouse, anti--rabbit (1:2,000; Sigma-Aldrich), or anti--protein A (1:5,000; Invitrogen) secondary antibodies were visualized using ECL Plus method with autoradiography films (GE Healthcare).

### Metabolic labeling.

Sciatic nerves from P28 WT and transgenic mice were dissected, desheathed, and placed in DMEM media lacking methionine and cysteine (Gibco) supplemented with 1% FCS, glutamine, and pyruvic acid, for 30 min at 37°C (starvation period), and then pulsed with ^35^S protein labeling mix (PerkinElmer) for 2 h. Proteins were extracted, quantified, and resolved by SDS-PAGE. The gel was then dried (Bio-Rad) and exposed with Biomax autoradiography films (GE Healthcare). Densitometric quantification was performed with ImageJ.

### Myelinating DRG explant cultures.

DRG were dissected from E13.5 WT and S63del embryos, and maintained in culture as previously described ([@bib64]). Myelination was induced with 50 µg/ml ascorbic acid (Sigma-Aldrich). Salubrinal (Tocris) was applied at the indicated concentration for 2--3 wk in parallel to the induction of myelination with ascorbic acid. The number of MBP-positive (see below) myelinated internodes was counted from 8--10 fields per DRG, from 6--8 DRG cultures per genotype.

### Behavioral, morphological, and electrophysiological analyses.

Motor capacity was assessed in 4-mo-old mice by rotarod analysis, as previously described ([@bib74]), on 20--25 mice per genotype. Electrophysiology was performed on 6-mo-old mice, as previously described ([@bib74]), on 8--12 animals per genotype. The number of amyelinated axons at P28, and demyelinated axons and onion bulbs at 6 mo were counted blind to genotype in semithin sections stained with toluidine blue in images acquired with a 100× objective as previously described ([@bib52]). We analyzed 2,000--3,000 fibers in 20--35 fields for each genotype in six WT, four *Gadd34*^Δc/Δc^, six S63del, and six S63del/*Gadd34*^Δc/Δc^ nerves. Semiautomated computer-based morphometry was performed on semithin sections of P28 and 6-mo-old sciatic nerve to determine the G-ratio and the distribution of fiber diameters for myelinated axons as described ([@bib51]). 6--15 microscopic fields from nerves of 4--6 animals per genotype were analyzed.

Immunofluorescent staining on sciatic nerve sections, teased fibers, and myelinating DRG explant cultures was performed as previously described ([@bib74]; [@bib43]) The following antibodies were used: chicken anti-P0 (1:2,000; Aves laboratories), mouse anti-KDEL (1:500; Stressgen), rat anti-MBP (1:5), rabbit anti-NF-H (1:1000; EMD Millipore); and TRITC- and FITC-conjugated secondary antibodies (1:200; Southern Biotech or Cappel). Specimens were incubated with DAPI (1:10,000), rinsed, mounted with VectaShield (Vector Laboratories), and viewed with a Leica DM5000B microscope. Images were collected with a Leica DFC480 digital color camera and processed with Adobe Photoshop CS4.

### Online supplemental material.

Fig. S1 shows the bioinformatic (GO) analyses performed with L2L for the genes up-regulated in S63del nerves at P28 and 4-months. Fig. S2 shows further GO analysis for the genes down-regulated in S63del nerves at P28 and 4-months. Fig. S3 presents the results of the GO analysis of the genes dysregulated in WT MPZ overexpressing (P0oe) sciatic nerves. Fig. S4 shows the results of the GO analysis of the 103 genes in the Venn diagram in [Fig. 3](#fig3){ref-type="fig"}. Table S1 lists the genes up-regulated in the mutant mice compared with WT at all the time-points analyzed. Table S2 lists the genes down-regulated in the mutant mice compared with WT at all the time-points analyzed. Table S3 lists the group of genes up-regulated in P0oe mice compared with WT at P28. Table S4 lists the group of genes down-regulated in P0oe mice compared with WT at P28. Table S5 lists the short group of genes that differ in expression between WT and *Chop*-null nerves. Table S6 lists the genes that are up-regulated in the mutant nerves and return toward WT levels after the ablation of *Chop* ("rescued" genes). Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20122005/DC1>.
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